MARKET

IBIO

IBIO

IBIO
AMEX

Real-time Quotes | Nasdaq Last Sale

2.220
-0.060
-2.63%
After Hours: 2.200 -0.02 -0.90% 19:56 07/10 EDT
OPEN
2.120
PREV CLOSE
2.280
HIGH
2.250
LOW
2.110
VOLUME
6.94M
TURNOVER
--
52 WEEK HIGH
3.400
52 WEEK LOW
0.0500
MARKET CAP
265.95M
P/E (TTM)
-1.8766
1D
5D
1M
3M
1Y
5Y

EPS

IBIO News

More
IBio Inc On July 6, Received Resignation Of CFO James P. Mullaney
Benzinga · 2d ago
Moderna completes enrollment in mid-stage study of COVID-19 vaccine
In a post on social media, Moderna (MRNA +2.0%) announces that it has completed enrollment in a Phase 2 clinical trial evaluating the safety, reactogenicit
seekingalpha · 3d ago
Why iBio Is an Excellent Pandemic Spec Play
InvestorPlace · 07/02 18:56
Smaller cap COVID-19 vaccine players under pressure on Pfizer data
Seeking Alpha - Article · 07/01 15:32
FDA guides on COVID-19 vaccine approval criteria
Seeking Alpha - Article · 06/30 16:01
GNW, IIPR among premarket losers
Seeking Alpha - Article · 06/30 12:15
NKLA, COTY among premarket gainers
Seeking Alpha - Article · 06/29 12:24
Coronavirus update: U.S. sets another record for new cases and some states scramble to revisit their reopening plans
marketwatch.com · 06/27 11:55

Industry

Pharmaceuticals
-0.31%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About IBIO

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
More

Webull offers kinds of Ibio Inc stock information, including AMEX:IBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IBIO stock methods without spending real money on the virtual paper trading platform.